INGN Q2 2023 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$84M-19.1% YoY

Gross Profit

$34M40.7% margin

Operating Income

-$12M-14.1% margin

Net Income

-$10M-11.7% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+15.9%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$374M

Total Liabilities

$100M

Stockholders' Equity

$275M

Cash & Equivalents

$168M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$103M	-19.1%
Gross Profit	$34M	$46M	-26.4%
Operating Income	-$12M	-$3M	-309.2%
Net Income	-$10M	-$3M	-185.5%

Geographic Segments

UNITED STATES

$60M72%

Non-US

$23M28%